Filing Details

Accession Number:
0001477449-24-000189
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-04 16:12:12
Reporting Period:
2024-08-30
Accepted Time:
2024-09-04 16:12:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2019394 L. James Cave C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Interim Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-30 339 $0.00 12,818 No 4 M Direct
Common Stock Acquisiton 2024-08-30 383 $0.00 13,201 No 4 M Direct
Common Stock Acquisiton 2024-08-30 1,162 $0.00 14,363 No 4 M Direct
Common Stock Disposition 2024-09-03 555 $7.16 13,808 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-08-30 339 $0.00 339 $0.00
Common Stock Restricted Stock Units Disposition 2024-08-30 383 $0.00 383 $0.00
Common Stock Restricted Stock Units Disposition 2024-08-30 1,162 $0.00 1,162 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
678 No 4 M Direct
1,151 No 4 M Direct
6,977 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  4. On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  5. On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.